Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis

Authors

  • Florence Wong M.D., F.R.A.C.P., F.R.C.P.C.,

    Corresponding author
    1. Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    • Address reprint requests to: Florence Wong, M.D., FRACP, FRCPC, Department of Medicine, Toronto General Hospital, 9th Floor, North Wing, Room 983, 200 Elizabeth Street, University of Toronto, Toronto, Ontario M5G 2C4, Canada. E-mail: florence.wong@utoronto.ca; fax: 416-340-5019.

    Search for more papers by this author
  • Patrick Murray M.D., F.A.S.N., F.R.C.P.I., F.J.F.I.C.M.I.

    1. UCD School of Medicine and Medical Science, Belfield, Dublin, Ireland
    Search for more papers by this author

  • Potential conflict of interest: Dr. Murray consults for and is on the speakers' bureau for Abbott. He consults for Astellas and AM Pharma. He advises EKF Diagnostics and FAST Diagnostics.

  • Dr. Murray's AKI biomarker research was supported by the Health Research Board (Ireland; grant HRA_POR 2011 128).

  • See Article on Page 622

No abstract is available for this article.

Ancillary